TIA-1 expression in hairy cell leukemia

We measured T-cell intracellular antigen-1 (TIA-1) expression in neoplastic cells from patients with hairy cell leukemia. Five of nine cases were positive for cytoplasmic TIA-1, with a small, dot-like, granular expression pattern. However, neoplastic cells were granzyme B- and perforin- negative in all cases. Other positive markers were CD20 in 9/9 cases, CD19 in 9/9 cases, DBA44 in 8/9 cases, LeuM5(CD11C) in 8/9 cases, IL-2R(CD25) in 7/9 cases, CD103 in 7/9 cases, FMC7 in 6/9 cases, and tartrate- resistant acid phosphatase in 5/7 cases. We also analyzed TIA-1 expression in 94 B cell lymphomas, including 19 diffuse, large cell lymphomas, 19 mantle cell lymphomas, six follicular lymphomas, two extranodal marginal zone B-cell lymphomas, 13 nodal marginal zone B-cell lymphomas, one mediastinal large-cell lymphoma, 19 diffuse small-cell lymphomas, 14 myelomas, and one splenic lymphoma with villous lymphocytes. All cases were negative for TIA-1 expression. Based on these findings, TIA-1 expression in neoplastic cells of low-grade B-cell lymphomas may be a good diagnostic marker for hairy cell leukemia. Moreover, TIA-1 reactivity in lymphomas does not necessarily indicate a T- or NK-cell derivation.

[1]  P. Gaulard,et al.  Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T‐cell lymphomas , 1997 .

[2]  B. Bouroncle,et al.  Leukemic reticuloendotheliosis. , 1958, Blood.

[3]  C. Berard,et al.  Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. , 1977, American journal of clinical pathology.

[4]  M. Yutsudo,et al.  Immunophenotypic features and configuration of immunoglobulin genes in hairy cell leukemia-Japanese variant. , 1996, Leukemia.

[5]  H. Bourbon,et al.  The developmentally-regulated Drosophila gene rox8 encodes an RRM-type RNA binding protein structurally related to human TIA-1-type nucleolysins. , 1993, Nucleic acids research.

[6]  I. W. Mclean,et al.  PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  E. Jaffe,et al.  Leukemic reticuloendotheliosis: presence of a receptor for cytophilic antibody. , 1974, The American journal of medicine.

[8]  J. Cawley,et al.  The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL). , 2003, Blood.

[9]  A. Sagone,et al.  Leukemic reticuloendotheliosis: A study of the origin of the malignant cell , 1975 .

[10]  J. Thiele,et al.  Hairy cell leukemia , 1976, Virchows Archiv A.

[11]  L. Yam,et al.  Hemopoietic inhibition in hairy cell leukemia , 1991, American journal of hematology.

[12]  C. Y. Wang,et al.  The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. , 1985, Blood.

[13]  E. Jaffe,et al.  Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. , 1997, Blood.

[14]  W. Donnelly,et al.  "Hairy" cells in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes. , 1966, Blood.

[15]  M. Streuli,et al.  Identification and functional characterization of a TIA-1-related nucleolysin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Shehata,et al.  Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia. , 1999, Blood.

[17]  J. Chan,et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. , 1997, Blood.

[18]  Y. Yamashita,et al.  Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection , 2000, Histopathology.

[19]  K. Oka,et al.  Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. , 1996, The American journal of pathology.

[20]  Paul Anderson,et al.  A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells , 1991, Cell.

[21]  C. Li,et al.  Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. , 1971, The New England journal of medicine.

[22]  T. Greiner,et al.  Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. , 1996, Blood.

[23]  J. Chan.  Neoplastic Hematopathology, 2nd ed. , 2001 .

[24]  G. Griffiths,et al.  Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. , 1991, Immunology today.

[25]  Y. Kagami,et al.  Lennert's Lymphoma: A Variant of Cytotoxic T-Cell Lymphoma? , 2000, The American journal of surgical pathology.

[26]  F. Naeim,et al.  Leukemic reticuloendotheliosis , 1974, Cancer.

[27]  Waleed F. Khalaf,et al.  Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested. , 2002, Leukemia research.

[28]  Y. Takeuchi,et al.  Perforin is expressed in CTL populations generated in vivo. , 1992, Immunology letters.

[29]  E. Jaffe,et al.  Hairy cell leukemia: a B cell neoplasm with a unique antigenic phenotype. , 1983, American journal of clinical pathology.

[30]  M. Ratain,et al.  Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. , 1988, American journal of clinical pathology.

[31]  N. Kedersha,et al.  Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Jaffe,et al.  T‐Cell Lymphoma Involving Subcutaneous Tissue: A Clinicopathologic Entity Commonly Associated with Hemophagocytic Syndrome , 1991, The American journal of surgical pathology.

[33]  Georges Delsol,et al.  Lennert’s Lymphoma , 1978 .

[34]  K. E. Salhany,et al.  TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. , 1997, The American journal of pathology.

[35]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[36]  J. Spivak,et al.  Commentary on and reprint of Bouroncle BA, Wiseman BK, Doan CA, Leukemic reticuloendotheliosis, in Blood (1958) 13:609–630 , 2000 .

[37]  P. Nowell,et al.  Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. , 2000, American journal of clinical pathology.

[38]  Sm Hus.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures , 1981 .

[39]  K. Takahashi,et al.  AN ULTRASTRUCTURAL STUDY WITH ENZYME‐LABELED ANTIBODY TECHNIQUE ON IMMUNOGLOBULIN‐CONTAINING CELLS IN HUMAN TONSILS, ESPECIALLY IN GERMINAL CENTERS , 1978, Acta pathologica japonica.

[40]  P. Anderson,et al.  Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. , 1996, Nucleic acids research.

[41]  S. Swerdlow,et al.  Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. , 1998, The American journal of surgical pathology.

[42]  P. Gaulard,et al.  Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. , 1990, The American journal of pathology.

[43]  J. Yang,et al.  Reassessment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis. , 1977, American journal of clinical pathology.

[44]  A. Chott,et al.  Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. , 1998, The American journal of pathology.

[45]  Y. Yamashita,et al.  Perforin and granzyme expression in cytotoxic T-cell lymphomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[46]  D. Catovsky,et al.  A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. , 1990, Blood.

[47]  T. Kitani,et al.  Predominance of a distinct subtype of hairy cell leukemia in Japan. , 1993, Leukemia.

[48]  I. Katayama,et al.  Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literature. , 1974, The American journal of medicine.

[49]  S. Asano,et al.  Significant expression of G‐CSF‐induced gene‐1 (GIG‐1) protein in myeloid cells and NK cells , 1999, Journal of leukocyte biology.